The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
ATALANTE-1 randomized phase III trial, OSE 2101 versus standard treatment as second- or third-line in HLA-A2 positive advanced non-small cell lung cancer (NSCLC) patients.
 
Enriqueta Felip
Consulting or Advisory Role - Abbvie; AstraZeneca; Blueprint Medicines; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Guardant Health; Lilly; Merck KGaA; Merck Sharp & Dohme; Novartis; Pfizer; Roche; Takeda
Speakers' Bureau - Abbvie; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; Merck KGaA; Merck Sharp & Dohme; Novartis; Pfizer; Roche; Takeda
Research Funding - EMD Serono (Inst); Merck (Inst)
 
Giuseppe Giaccone
Consulting or Advisory Role - ARMO BioSciences; BerGenBio; G1 Therapeutics
Research Funding - Bayer; Incyte; Lilly
 
Rafal Dziadziuszko
Consulting or Advisory Role - AstraZeneca
 
Fabrice Denis
Consulting or Advisory Role - Sividon Diagnostics (Inst)
Speakers' Bureau - Chugai Pharma
Research Funding - Sividon Diagnostics (Inst)
Patents, Royalties, Other Intellectual Property - Royalties sharing agreements (Inst)
Travel, Accommodations, Expenses - Roche
Other Relationship - Chugai Pharma; Ferring; Ipsen; Janssen-Cilag; Merck Serono; Novartis; Takeda
 
Teresa Moran
No Relationships to Disclose
 
Didier Debieuvre
Honoraria - Boehringer Ingelheim; Bristol-Myers Squibb; Roche (I)
Consulting or Advisory Role - Bristol-Myers Squibb; MSD; Novartis; Pfizer (I); Roche
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Chugai Pharma (Inst); Lilly (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Boehringer Ingelheim; Bristol-Myers Squibb; Roche
 
Manuel Cobo
No Relationships to Disclose
 
Domenico Galetta
Consulting or Advisory Role - Boehringer Ingelheim; MSD; Roche
Speakers' Bureau - Bristol-Myers Squibb; Lilly; MSD travel grant; Roche
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Lilly; MSD travel grant; Roche
 
François Roger Vanel
No Relationships to Disclose
 
Giampiero Romano
No Relationships to Disclose
 
Anne Madroszyk
No Relationships to Disclose
 
Christos Chouaid
Honoraria - Roche, Amgen, BMS, MSD, AZ, BI, Novartis, Pfizer, Takeda
Consulting or Advisory Role - Roche, MSD, BMS, AZ,; Roche, MSD, BMS, AZ,
Research Funding - AZ, BMS, MSD, PF, Takeda, Pfizer, Novartis, Roche (Inst)
Travel, Accommodations, Expenses - AZ, Roche, Pfizer, MSD, BMS, BI; AZ, Roche, Pfizer, MSD, BMS, BI
 
Francois-Regis Ferrand
No Relationships to Disclose
 
Werner Hilgers
Consulting or Advisory Role - AstraZeneca; Janssen; Roche; Sanofi
Travel, Accommodations, Expenses - Astellas Medivation; AstraZeneca; Janssen; Roche
 
Federico Cappuzzo
Consulting or Advisory Role - AstraZeneca/MedImmune; Bristol-Myers Squibb; pfizer; Roche/Genentech; Takeda
 
Philippe Masson
No Relationships to Disclose
 
Nir Peled
Consulting or Advisory Role - Advisor & Honorarium for AZ, BI, BMS, Lilly , MSD, Novartis, pfizer, Roche
Speakers' Bureau - Advisor & Honorarium for AZ, BI, BMS, Lilly , MSD, Novartis, pfizer, Roche
 
Berangere Vasseur
Employment - OSE Immunotherapeutics
 
Jordi Remon
Consulting or Advisory Role - Boehringer Ingelheim; Bristol-Myers Squibb; MSD Oncology; Pfizer
Travel, Accommodations, Expenses - Inivata; OSE Immunotherapeutics; OSE Immunotherapeutics; Roche/Genentech
 
Benjamin Besse
Research Funding - Abbvie (Inst); Amgen (Inst); AstraZeneca (Inst); Biogen (Inst); Blueprint Medicines (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); GlaxoSmithKline (Inst); Ignyta (Inst); Inivata (Inst); Ipsen (Inst); Lilly (Inst); Merck KGaA (Inst); MSD Oncology (Inst); Nektar (Inst); Onxeo (Inst); Pfizer (Inst); PharmaMar (Inst); Sanofi (Inst); Spectrum Pharmaceuticals (Inst); Takeda (Inst); Tiziana Therapeutics (Inst)